Pharmablock Sciences Nanjing Co., Ltd. is a pharmaceutical company primarily engaged in the development, manufacture, and sale of chemical building blocks and drugs. It offers its products and services to facilitate new drug discovery, development, and production. The company’s unique capabilities are in the flexible and efficient synthesis of tailored chemical building blocks, which are crucial for the dynamic nature of pharmaceutical research. Pharmablock Sciences caters to a diverse clientele including pharmaceutical corporations, biotechnology companies, and research institutions. With its significant contributions to drug innovation pipelines, the company supports various therapeutic areas, particularly in small molecule drug development. Based in Nanjing, China, Pharmablock Sciences holds a prominent position in the global pharmaceutical supply chain, thanks to its commitment to high-quality manufacturing standards and innovation in chemical designs. Its role is vital in accelerating the drug development process, providing essential resources for creating novel diagnostic and therapeutic solutions.
Markedsdata leveret af TwelveData og Morningstar
Baseret på 1 analytiker